Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Radiofluorination and docking studies for [18F]FEt-Tyr-urea-Glu ([18F]FEt-TUG) as a new potential PSMA ligand

Noeen Malik, Ehab Al-Momani, Hans Machulla, Philip Reigan, Peter Smith-Jones, Sven Reske and Christoph Solbach
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1013;
Noeen Malik
1Clinic for Nuclear Medicine, University Hsopital Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ehab Al-Momani
1Clinic for Nuclear Medicine, University Hsopital Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Machulla
1Clinic for Nuclear Medicine, University Hsopital Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Reigan
3School of Pharmacy, Anschutz Medical Campus, University of Colorado, Denver, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Smith-Jones
2Radiology, Anschutz Medical Campus, University of Colorado, Denver, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Reske
1Clinic for Nuclear Medicine, University Hsopital Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Solbach
1Clinic for Nuclear Medicine, University Hsopital Ulm, Ulm, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1013

Objectives For PET-imaging, various PSMA ligands have been synthesized based on glutamate-urea-amino acids moieties. We prepared a peptide, Tyr-urea-Glu, for labeling it by using [18F]FEt-Tosyl as prosthetic group. The synthesis was to be prepared for automation while docking studies were supposed to substantiate the possible application as PSMA ligand.

Methods The precursor i.e. (S)-2-[3-[(S)-1-Carboxy-2-(4-hydroxyphenyl)ethyl]-ureido]pentanedioic acid was prepared by coupling of bis(tert-butyl)-L-glutamate.HCl and L-tyrosine tert-butyl ester. Radiofluorination was performed by [18F]FEt-Tosyl produced in a module. After elution from C18-cartridge (ca. 510 MBq), it was heated at 80°C (15min) with peptide (3mg/15µL of 10M NaOH, 18eq). Then, peak of [18F]FEt-TUG (HPLC: Phenomenex Luna; 100%water/0.1%TFA to 40%MeCN/0.1%TFA at 10min to 20min; 5mL/min, Rt: 12min) was fixed on C18-cartridge, eluted by EtOH, evaporated and diluted with saline (450µL) ([18F]FEt-TUG, radiochemical purity: ≥98%, ca.100MBq). For calculating binding energies with protein, analysis was performed using Discovery Studio 3.1.

Results Efficiency of coupling between [18F]FEt-Tosyl and -OH group of peptide depended on base. With 14mg (20eq) of NaHCO3, 40±1% (15min) RCY was obtained at 90°C. Using 15µL of 10M NaOH (18eq), RCY increased to 77±0.8%. Binding affinity data of [18F]FEt-TUG (Calc. BE: 278kcal/mol) was compared to existing compounds like ZJ38, ARM-P, and DCFPyL (Fig 1). Also, docking studies showed that it filled the PSMA tunnel (70Å) with urea moiety reaching near Zn-atoms. In addition, LogD values were calculated by ACD-Freeware (Fig 1).

Conclusions An efficient method for radiosynthesis of a new PSMA ligand i.e. [18F]FEt-TUG was developed. The calculations showed similar binding affinities when compared to known PSMA-ligands indicating a promising applicability.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiofluorination and docking studies for [18F]FEt-Tyr-urea-Glu ([18F]FEt-TUG) as a new potential PSMA ligand
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiofluorination and docking studies for [18F]FEt-Tyr-urea-Glu ([18F]FEt-TUG) as a new potential PSMA ligand
Noeen Malik, Ehab Al-Momani, Hans Machulla, Philip Reigan, Peter Smith-Jones, Sven Reske, Christoph Solbach
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1013;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiofluorination and docking studies for [18F]FEt-Tyr-urea-Glu ([18F]FEt-TUG) as a new potential PSMA ligand
Noeen Malik, Ehab Al-Momani, Hans Machulla, Philip Reigan, Peter Smith-Jones, Sven Reske, Christoph Solbach
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1013;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • A radioactive method for assessing microbial safety of an infusion set for contrast-enhanced imaging
  • Cathepsin K inhibitors for in vivo osteoclast imaging by PET
  • Nonradioactive analytical methods for quantifying the modification ratio of antibody chelator conjugates (ACCs) with deferroxamine and DOTA
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Special MTA: Automation and Development

  • Novel approach for solid-phase radiosynthesis of 18F-Fluoroacetate: Comparison between one-pot and two-pot distillation procedure
  • Production optimization of 68Ga-DOTA-NOC for routine synthesis
  • Development of a tri-functional chelator based on sarcophagine cage
Show more Special MTA: Automation and Development

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire